- Home
- CYBN vs PINE Comparison
CYBN vs PINE Comparison
Compare CYBN & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- PINE
- Stock Information
- Founded
- CYBN 2019
- PINE 2019
- Country
- CYBN Canada
- PINE United States
- Employees
- CYBN N/A
- PINE N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- PINE Real Estate Investment Trusts
- Sector
- CYBN Health Care
- PINE Real Estate
- Exchange
- CYBN Nasdaq
- PINE Nasdaq
- Market Cap
- CYBN 176.5M
- PINE 200.1M
- IPO Year
- CYBN N/A
- PINE 2019
- Fundamental
- Price
- CYBN $6.08
- PINE $14.66
- Analyst Decision
- CYBN Strong Buy
- PINE Strong Buy
- Analyst Count
- CYBN 3
- PINE 5
- Target Price
- CYBN $85.00
- PINE $18.30
- AVG Volume (30 Days)
- CYBN 625.2K
- PINE 71.4K
- Earning Date
- CYBN 11-12-2025
- PINE 10-16-2025
- Dividend Yield
- CYBN N/A
- PINE 7.77%
- EPS Growth
- CYBN N/A
- PINE N/A
- EPS
- CYBN N/A
- PINE N/A
- Revenue
- CYBN N/A
- PINE $56,340,000.00
- Revenue This Year
- CYBN N/A
- PINE $14.51
- Revenue Next Year
- CYBN N/A
- PINE $0.12
- P/E Ratio
- CYBN N/A
- PINE N/A
- Revenue Growth
- CYBN N/A
- PINE 17.14
- 52 Week Low
- CYBN $4.81
- PINE $13.95
- 52 Week High
- CYBN $13.88
- PINE $18.79
- Technical
- Relative Strength Index (RSI)
- CYBN 38.92
- PINE 43.30
- Support Level
- CYBN $6.16
- PINE $15.10
- Resistance Level
- CYBN $6.55
- PINE $15.36
- Average True Range (ATR)
- CYBN 0.49
- PINE 0.23
- MACD
- CYBN -0.06
- PINE -0.06
- Stochastic Oscillator
- CYBN 12.90
- PINE 0.00
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.